Tuesday, December 16, 2025
HomeNews

News

Theralink Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

Theralink Technologies, Inc, a precision oncology company with a novel phosphoprotein and protein assay for breast cancer, announced that it has acquired an exclusive...

ThreatHunter.ai: Pioneering a Unique AI and Human Expertise-Based Cybersecurity Solution

ThreatHunter.ai has created an innovative cybersecurity solution to address the common challenges faced by companies, including alert fatigue, improper system tuning, outdated threat intelligence,...

2023 New York International Auto Show Guests Use Artificial Intelligence to Create their Picture-Perfect Lexus

It's not hard to imagine your picture-perfect 2023 Lexus RX or 2023 Lexus RZ 450e luxury utility vehicle. But, it's even better to envision it on your own...

Precigen Regains Exclusive Rights to Proven CAR-T Targets, CD19 and BCMA, to Enable Unencumbered Development and Commercialization of UltraCAR-T

Precigen, Inc, a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced the amendment...

EQT And Context Labs Announce Strategic Partnership

EQT Corporation and Context Labs announced the establishment of a strategic partnership to advance the commercialization of verified low carbon intensity natural gas products...
0FansLike
0FollowersFollow
spot_img

Hot Topics